|Articles|February 17, 2016
Parexel Launches Genomic Medicine Team
The team joined Parexel from GlaxoSmithKline’s Genetics and Computational Biology departments and expands capabilities in genomic-based drug development.
Advertisement
Parexel has expanded services and capabilities in genomic-based drug development with its Genomic Medicine team. The team is comprised of more than 15 scientists with combined expertise in genomics, drug discovery, and drug development, who joined Parexel from GlaxoSmithKline’s Genetics and Computational Biology departments. The team will meet clients’ expected increased needs for the number of personalized medicines that will require genomic information to inform decision-making on the clinical utility and value for the intended patient population.
Read the full release .
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- How Sponsors Can Modernize Tools to Support Physicians
September 9th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief Episode 7: Veeva and Merck Trial Efficiency, DCT Barriers, and Glucose Monitoring Strategies
2
Pfizer, BioNTech’s Comirnaty Shows Strong Immune Response in Phase III Trial for COVID-19
3
Beyond the Algorithm: How Human-Centered AI Design Can Drive Clinical Trial Success
4
Summit Therapeutics’ Bispecific Antibody Shows Positive Survival Trend in Non-Small Cell Lung Cancer
5